by Elodie Smith, Cornell University Tracking recruitment of hair follicle McSCs to the epidermis by UVB on unpigmented mouse dorsal skin. Credit: Nature Communications (2024). DOI: 10.1038/s41467-024-45034-3Patients with an appearance-altering skin condition may have relief thanks to an unlikely cocktail of a molecule that induces labor, an immunosuppressant medication and controlled UVB irradiation. This College of...
by Elana Gotkine Transplant recipients, especially those receiving hematopoietic stem cell transplant (HSCT), have an increased risk for vitiligo, according to a brief report published online Dec. 13 in JAMA Dermatology. Chul Hwan Bang, M.D., Ph.D., from the Catholic University of Korea in Seoul, and colleagues conducted a population-based cohort study including data from the...
Caroline Guignot November 06, 2023 International vitiligo experts have published new recommendations in two parts — one dedicated to management algorithms, the other to specific treatment recommendations — to update the text from 2013. These recommendations are aimed at dermatologists and primary care providers and propose relatively simple algorithms. Julien Seneschal, MD, PhD, professor of dermatology at...
The study appears in the journal JCI Insight. “In this study, we couple advanced imaging with transcriptomics and bioinformatics to discover the cell-to-cell communication networks between keratinocytes, immune cells and melanocytes that drive inflammation and prevent re-pigmentation caused by vitiligo,” says Anand K. Ganesan, professor of dermatology and vice chair for dermatology research at the University...
(HealthDay)—Atopic dermatitis (AD) is associated with vitiligo, according to a review and meta-analysis published online Dec. 24 in the Journal of Cosmetic Dermatology. Prakash Acharya, M.B.B.S., M.D., and Mahesh Mathur, M.D., from the College of Medical Sciences in Bharatpur, India, conducted a meta-analysis of observational studies to compare the prevalence and risk of vitiligo in...
Rania Abdelghani, M.D., from Al-Azhar University in Cairo, and colleagues randomly assigned 80 adult patients with localized non-segmental vitiligo to receive four treatment options: fractional CO2 laser, PRP, combined fractional CO2 laser and PRP, or combined fractional CO2 laser and narrowband ultraviolet B (NB-UVB)—all for two months. The researchers found that the laser and PRP group achieved the best results...
